SBRANasdaqReal Estate Investment TrustsFiscal year ends December 31
Sabra Health Care REIT, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$19.08−0.26 (-1.34%)
Close on Oct 19, 2026
- Market cap
- $4.81B
- P/E (TTM)
- 73.4
- Dividend yield
- 6.29%
Sabra Health Care REIT, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ancillary services | $4.90M | $3.90M | $2.00M | $1.50M | $1.30M | $900.00K | $800.00K | – | – | 0.6% | +25.6% |
| Ancillary Services | – | – | – | – | – | $900.00K | $800.00K | $500.00K | $300.00K | – | – |
By region
From the segment and revenue-disaggregation notes of Sabra Health Care REIT's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.